Cyclopharm Limited Financial Overview
Cyclopharm Limited's market cap is currently AU$70.02M. The company's EPS TTM is AU$-0.07; its P/E ratio is -5.38; Cyclopharm Limited is scheduled to report earnings on August 27, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
